FDA Inspection 1063131 — Community Blood Center
The FDA completed an inspection of Community Blood Center on Jun 26, 2018 in Memphis, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 26, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Memphis, TN (United States)